Amaero has released A$2.961 million of restricted cash after renegotiating its EXIM loan, while its proposed US IPO moves through an amended SEC filing. Preliminary September figures show revenue of up to A$5.833 million, but operating cash use remained close to A$9 million.
- A$2.961 million of EXIM-restricted cash released immediately
- September quarter revenue estimated at A$5.607 million to A$5.833 million
- Backlog estimated at roughly A$19.25 million
- First EXIM liquidity covenant test deferred to September 2028
- US IPO registration statement remains subject to SEC effectiveness
Amaero releases A$2.96 million of restricted cash
Amaero Inc (ASX:3DA) has secured an immediate liquidity release while advancing its proposed US initial public offering, with an amendment to its Export-Import Bank of the United States loan freeing A$2.961 million previously held in a pledged collateral account.
The amendment cuts the required collateral balance from 20% of the outstanding loan to 10%. On the company’s estimates, that would lift cash and cash equivalents at 30 September 2026 to between A$10.056 million and A$10.070 million, compared with the preliminary reported range of A$7.095 million to A$7.109 million before the release.
The relief comes with tighter security over the financing. EXIM’s collateral package has been expanded to cover substantially all assets of Amaero, its borrower and other guarantors. The first liquidity covenant test has also been pushed back from 30 September 2027 to 30 September 2028, giving the company more time before that test begins.
US IPO filing adds preliminary September figures
Amaero filed Amendment No. 3 to its Form S-1 registration statement with the US Securities and Exchange Commission. The filing updates the proposed offering with management estimates for the quarter ended 30 September, following the draft US IPO filing submitted earlier in the year, when pricing and timing had not been set.
Revenue is estimated at A$5.607 million to A$5.833 million, while backlog sits in a narrow range of A$19.249 million to A$19.263 million. Net cash used in operating activities is estimated at A$8.991 million to A$9.260 million for the quarter, a sizeable cash outflow alongside the company’s reported revenue and order pipeline.
Those figures are preliminary, unaudited management estimates rather than completed quarterly accounts. The registration statement has not yet been declared effective, and the announcement provides no offering size, share price or timetable. The next material test for the transaction is therefore not simply whether the filing has been amended, but whether it clears the SEC process and produces definitive terms for investors.
Bottom Line?
The EXIM amendment improves near-term cash availability and delays covenant testing, but the expanded collateral package and continued operating cash use keep financing terms central to Amaero’s IPO story.
Questions in the middle?
- Will the SEC declare Amaero’s registration statement effective, and on what offering terms?
- Can the company convert its roughly A$19.25 million backlog into cash without sustaining similar operating outflows?
- How will the expanded EXIM collateral package affect financial flexibility as the business scales?